Caristo Diagnostics Recognized as a Quarterfinalist for Digital Health Award
Caristo Diagnostics Achieves Quarterfinalist Status in Digital Health Awards
Caristo Diagnostics, a forefront player in cardiovascular disease diagnostics, has been named a quarterfinalist in the highly esteemed Digital Health Hub Foundation: Digital Health Awards. The company has been recognized specifically in the Rising Star Provider Diagnostics category.
Highlighting Innovation and Commitment
This recognition underscores Caristo's commitment to revolutionizing the approach to heart disease by addressing hidden inflammation, which is crucial in the prevention of heart attacks. The Digital Health Awards celebrate organizations like Caristo, which are dedicated to enhancing healthcare systems through innovative digital technologies. As a distinguished quarterfinalist, Caristo reflects a robust dedication to leveraging advanced artificial intelligence in the diagnosis of cardiovascular conditions, enabling healthcare professionals to better evaluate and treat coronary artery disease, the leading cause of death worldwide.
CEO's Perspective on the Achievement
Frank Cheng, the CEO of Caristo Diagnostics, expressed gratitude for the recognition, stating, "We are deeply honored to be identified as a quarterfinalist in the Provider Diagnostics category of the Digital Health Awards. This achievement not only represents our ongoing efforts to enhance heart health but also the positive results our clients experience through our innovative technologies."
Competing Among the Best
The competition was fierce, with over 1,500 submissions received, and only 15 quarterfinalists advancing in each category. This selection process showcases the depth of talent and innovation in the digital health sector.
Scientific Validation and Technology Availability
Recent findings published in The Lancet highlight the limitations of current diagnostics focused on obstructive coronary artery disease, revealing that they overlook two-thirds of significant cardiac events. Caristo's proprietary technology, CaRi-Heart, measures coronary inflammation, enabling it to identify this hidden yet treatable factor in disease progression.
Where CaRi-Heart Technology Is Available
Currently, CaRi-Heart technology is accessible in the European Union, the United Kingdom, and Australia. The team is also pursuing clearance from the US Food & Drug Administration to expand its availability.
Insights from the Digital Health Hub Foundation
Mark Goldstein, the Chairman of the Digital Health Hub Foundation, remarked, "This year has set a new benchmark for excellence, with an impressive array of global submissions showcasing extraordinary innovations in digital health. The creativity and commitment displayed are truly inspiring. Congratulations to all of our quarterfinalists for their impressive achievements."
Looking Ahead: Finalists and Winners Announcements
Finalists for the awards are scheduled to be announced soon, with the winners revealed during the Grand Finale at HLTH. The anticipation is building as the healthcare community awaits the recognition of the most impactful digital health innovations.
About Caristo Diagnostics
Caristo Diagnostics is a leader in the field of diagnostics related to cardiac and vascular diseases. Established in 2018 as a spin-off from the University of Oxford, Caristo has developed a range of imaging-based and AI-enhanced platforms aimed at predicting and diagnosing heart attacks, strokes, and diabetes. The company has been recognized by Newsweek as one of the premier digital health companies and acknowledged by Nature as one of the most exciting science-based enterprises emerging from academic research. Connect with Caristo through its website, LinkedIn, and X.
About Digital Health Hub Foundation
The Digital Health Hub Foundation is devoted to empowering innovative healthcare companies to scale effectively. Founded in 2017 on the UCSF campus, this community now consists of 30,000 members, including healthcare companies at various stages, providers, payers, and industry experts who come together for an annual awards ceremony that celebrates achievements in healthcare technology.
Contact Information
For inquiries, please reach out to Frank Cheng, CEO of Caristo Diagnostics, at [email protected].
Frequently Asked Questions
What are the Digital Health Awards?
The Digital Health Awards celebrate organizations that enhance healthcare through digital innovation and technologies.
What technology does Caristo Diagnostics use?
Caristo uses its proprietary CaRi-Heart technology to measure coronary inflammation, aiding in cardiovascular disease diagnosis.
Where is Caristo's technology available?
CaRi-Heart is available in the EU, the UK, and Australia, with plans for expansion to the US.
Who is the CEO of Caristo Diagnostics?
Frank Cheng serves as the CEO of Caristo Diagnostics and has expressed gratitude for the company's recognition in the Digital Health Awards.
When will finalists and winners be announced?
Finalists will be announced shortly, and winners are expected to be revealed at the Grand Finale event at HLTH in the near future.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Super Micro Computer Responds to Hindenburg's Allegations
- QIAGEN N.V. Launches New Convertible Bonds for Expansion
- Equature's 2024.3 Software Revolutionizes Public Safety Operations
- Leinco Technologies Inc. Expands Portfolio with QED Biosciences
- Jamie Foxx Brings Humor to BetMGM's 2024 Football Campaign
- Wipfli Unveils 2024 Annual Report Detailing Growth and Innovation
- Autonomous Cars Forecast: Growth to USD 43.44 Billion By 2032
- Exdion Insurance Unveils CSRdigit: Revolutionizing E&O Protection
- Sippable Delight: Baileys Cinnamon Churros Cream Liqueur
- Investing Insights: Nvidia Versus Arm Holdings in AI Sector
- Agmatix Unveils RegenIQ: Revolutionizing Regenerative Agriculture
- BoomerangFX Expands Innovative Solutions in Asia and Latin America
- Trethom AS Reduces Major Shareholding in Vow ASA Below 5%
- Costco to Expand with Four New Locations by End of 2024
- Supermicro Addresses Concerns Over Annual Report Filing
- Bloomberg CityLab 2024: Global Mayors Gather in Mexico City
- BCFNJC's What We Heard Report from First Nations Justice Forum
- Asia Pacific Wireless Earphones Market Expected to Thrive
- Cork Packaging Market Expected to Hit USD 2.7 Billion Growth
- MICE Industry Expected to Reach $1,337 Billion by 2033
- Packaging Automation Market Growth Driven by E-commerce Boom
- Tilray Brands Strengthens Craft Beer Portfolio with Acquisition
- Status of Audit for Aktsiaselts Silvano Fashion Group Revealed
- CapexMD Welcomes Alex Shire as New CEO in Exciting Shift
- Tiny Traveler Unveils Advanced AI Baby Monitor for Parents
Recent Articles
- Packaging Automation Market Growth Driven by E-commerce Boom
- Tiny Traveler Unveils Advanced AI Baby Monitor for Parents
- CaringBridge Welcomes New Board Members and Leadership Roles
- Decisely Proudly Partners with Stewart-Haas Racing in NASCAR
- Florida Crystals® Marks Organic Month with Milestones and New Packaging
- Light The Night: Illuminate Hope for Blood Cancer Patients
- Procaps Group Outlines Strategic Vision for Future Success
- Caristo Diagnostics Recognized as a Quarterfinalist for Digital Health Award
- Steward Healthcare Faces Bankruptcy Challenges Next Week
- Trio Petroleum Corp Boosts Oil and Gas Reserves Estimates
- LM Funding America, Inc. Gears Up for H.C. Wainwright Conference
- Understanding Distributions from Allspring Utilities Fund (ERH)
- Nvidia's Stellar Growth: Should You Buy Shares Now?
- Anavex Life Sciences Teams Up with H.C. Wainwright's Conference
- Juli Saitz Appointed as Senior Managing Director at FTI Consulting
- Axxess and Transcend Strategy Group Collaborate for Growth
- Exploring AI Investment Opportunities with Palantir and AMD
- Troilus Gold Reports Encouraging Drill Results from West Rim Zone
- Intel Faces Dow Removal Threat Amid Share Price Slump
- Discover Peace of Mind at Fall Open House Event
- JinkoSolar Provides Over 1,000 Solar Modules for Relief
- Join the Class Action Against Indivior PLC (INDV) Now
- MacroGenics, Inc. Investors Encouraged to Contact Legal Team
- Vicor Corporation Faces Class Action Lawsuit: Key Insights
- Dior Welcomes Miu Miu CEO Benedetta Petruzzo as MD